90 related articles for article (PubMed ID: 12184309)
1. Firm signs consent decree prohibiting ephedrine products.
FDA Consum; 2002; 36(4):5. PubMed ID: 12184309
[No Abstract] [Full Text] [Related]
2. Ephedrine's deadly edge.
Turk MP
US News World Rep; 1997 Jul; 123(1):79-80. PubMed ID: 10168348
[No Abstract] [Full Text] [Related]
3. Postmarketing studies for approved human drug and licensed biological products; status reports. Food and Drug Administration, HHS. Final rule.
Fed Regist; 2000 Oct; 65(210):64607-19. PubMed ID: 11503687
[TBL] [Abstract][Full Text] [Related]
4. Roadmap for revitalization?
Nat Biotechnol; 2007 Oct; 25(10):1061. PubMed ID: 17921973
[No Abstract] [Full Text] [Related]
5. Drug approval system questioned in US and Canada.
Eggertson L
CMAJ; 2005 Feb; 172(3):317-8. PubMed ID: 15684107
[No Abstract] [Full Text] [Related]
6. Applications for Food and Drug Administration application approval to market a new drug; revision of postmarketing reporting requirements. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2007 Oct; 72(201):58993-9000. PubMed ID: 17966558
[TBL] [Abstract][Full Text] [Related]
7. FDA set to tighten guidelines on industry dissemination of information on unapproved uses of medical products.
Lang L
Gastroenterology; 2008 Apr; 134(4):905. PubMed ID: 18395067
[No Abstract] [Full Text] [Related]
8. US Senate passes FDA Revitalization Act.
Guthrie P
CMAJ; 2007 Jul; 177(1):23. PubMed ID: 17606930
[No Abstract] [Full Text] [Related]
9. The federal ban on ephedrine dietary supplements:an important event for pain practitioners and patients.
Lipman AG
J Pain Palliat Care Pharmacother; 2004; 18(3):1-4. PubMed ID: 15364627
[No Abstract] [Full Text] [Related]
10. Comparative regulation of drug and aircraft development: lessons for regulatory reform?
Urquhart J
Clin Pharmacol Ther; 1997 Dec; 62(6):583-6. PubMed ID: 9433385
[No Abstract] [Full Text] [Related]
11. The Prescription Drug User Fee Act: is a faster Food and Drug Administration always a better Food and Drug Administration?
Zelenay JL
Food Drug Law J; 2005; 60(2):261-338. PubMed ID: 16094773
[No Abstract] [Full Text] [Related]
12. Medicine. Ephedra--scientific evidence versus money/politics.
Wolfe SM
Science; 2003 Apr; 300(5618):437. PubMed ID: 12702860
[No Abstract] [Full Text] [Related]
13. FDA attempting to overcome major roadblocks in monitoring drug safety.
Zielinski SL
J Natl Cancer Inst; 2005 Jun; 97(12):872-3. PubMed ID: 15956645
[No Abstract] [Full Text] [Related]
14. The FDA, regulation, and the risk of stroke.
Fleming GA
N Engl J Med; 2000 Dec; 343(25):1886-7. PubMed ID: 11117982
[No Abstract] [Full Text] [Related]
15. Tempered enthusiasm. Drug-safety law needs more teeth, patient-safety advocates say.
DerGurahian J
Mod Healthc; 2007 Oct; 37(40):16. PubMed ID: 18018373
[No Abstract] [Full Text] [Related]
16. FDA warns sellers of nicotine lollipops, lip balm.
FDA Consum; 2002; 36(4):5-6. PubMed ID: 12184310
[No Abstract] [Full Text] [Related]
17. Prepare for the long haul of drug monitoring.
Gliklich R
Nat Med; 2010 Aug; 16(8):848. PubMed ID: 20689542
[No Abstract] [Full Text] [Related]
18. The Food and Drug Administration's use of postmarketing (Phase IV) study requirements: exception to the rule?
Steenburg C
Food Drug Law J; 2006; 61(2):295-383. PubMed ID: 16903034
[No Abstract] [Full Text] [Related]
19. Making medicines safer--the need for an independent drug safety board.
Wood AJ; Stein CM; Woosley R
N Engl J Med; 1998 Dec; 339(25):1851-4. PubMed ID: 9854125
[No Abstract] [Full Text] [Related]
20. The complexity of integrating speed and safety in drug development and approval.
Charo RA
JAMA Intern Med; 2013 Jul; 173(13):1165-6. PubMed ID: 23568604
[No Abstract] [Full Text] [Related]
[Next] [New Search]
